Rubitecan CAS:91421-42-0 is a potent topoisomerase I inhibitor, belonging to the camptothecin family of natural products. Derived from the tree Camptotheca acuminata, this functional group exhibits significant anticancer properties by targeting the topoisomerase I enzyme, essential for DNA replication and cell division.
Introduction to the application:
In pharmaceutical research and development, Rubitecan is extensively studied for its promising anticancer potential. Its unique mechanism of action, targeting topoisomerase I, enables the disruption of DNA replication and cell division in cancer cells, leading to apoptosis. Rubitecan has demonstrated efficacy against a wide range of malignancies, including pancreatic, ovarian, and small cell lung cancers, positioning it as a valuable candidate in cancer therapeutics.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.
